However, raw incidence numbers do not reflect individual risk
Treatment with semaglutide or tirzepatide always requires a medical assessment, regular monitoring of effects and side effects, and should be combined with lifestyle support
Chang works closely with each patient to ensure that the treatment plan remains effective and aligned with their health goals
[5] [6] La evidencia de ensayos como LEADER (liraglutida) y REWIND (dulaglutida) sugiere que los beneficios cardiovasculares y renales de estos medicamentos persisten mientras se mantiene el tratamiento, aunque estos beneficios varan segn el agente especfico
Tirzepatide and retatrutide have many similar potential side effects, including: nausea diarrhea constipation acid reflux decreased appetite Anyone on a weight loss med should be monitored by a clinician, who can keep an eye on your progress and help you navigate common side effects
Retatrutide does not yet have a published head-to-head trial comparing it to the other two drugs